YP
CRL icon

YANKCOM Partnership’s Charles River Laboratories CRL Stock Holding History

YANKCOM Partnership’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$19.5K Hold
86
– – 0.01% 230
2026
Q1 		$14.8K Hold
86
– – 0.01% 251
2025
Q4 		$17.2K Hold
86
– – 0.01% 250
2025
Q3 		$13.5K Hold
86
– – 0.01% 231
2025
Q2 		$13K Buy
86
+67
+353% +$8.94K 0.01% 226
2025
Q1 		$2.86K Sell
19
-482
-96% -$80.8K ﹤0.01% 265
2024
Q4 		$92.5K Buy
+501
New +$96.5K 0.05% 161

Other funds holding CRL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.65B AUM 9.66% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
VBA
Van Berkom & Associates Montreal, Quebec, Canada $3.1B AUM 12.88% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

YANKCOM Partnership's CRL Position: Q2 2026 in Review

YANKCOM Partnership held its Charles River Laboratories (CRL) position steady in Q2 2026 at 86 shares worth $19.5K. The position accounts for 0.01% of the portfolio, ranked #230.

YANKCOM Partnership first reported a position in CRL in Q4 2024 and has held it in 7 quarters since. The position peaked at $92.5K in Q4 2024. 248 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • YANKCOM Partnership held 86 shares of Charles River Laboratories worth $19.5K as of Q2 2026.
  • YANKCOM Partnership left its Charles River Laboratories share count unchanged in Q2 2026.
  • Charles River Laboratories made up 0.01% of YANKCOM Partnership's portfolio in Q2 2026, its #230 holding.
  • YANKCOM Partnership first reported a position in Charles River Laboratories in Q4 2024 and has held it in 7 quarters since.
  • YANKCOM Partnership's Charles River Laboratories position peaked at $92.5K in Q4 2024.
  • 248 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on YANKCOM Partnership's 13F filing for Q2 2026, filed 21 Jul 2026.